Literature DB >> 17035327

Contribution of T-cell receptor repertoire breadth to the dominance of epitope-specific CD8+ T-lymphocyte responses.

Edwin R Manuel1, William A Charini, Pritha Sen, Fred W Peyerl, Marcelo J Kuroda, Jörn E Schmitz, Patrick Autissier, Dennis A Sheeter, Bruce E Torbett, Norman L Letvin.   

Abstract

Dominant epitope-specific CD8(+) T-lymphocyte responses play a central role in controlling viral spread. We explored the basis for the development of this focused immune response in simian immunodeficiency virus (SIV)- and simian-human immunodeficiency virus (SHIV)-infected rhesus monkeys through the use of two dominant (p11C and p199RY) and two subdominant (p68A and p56A) epitopes. Using real-time PCR to quantitate T-cell receptor (TCR) variable region beta (Vbeta) family usage, we show that CD8(+) T-lymphocyte populations specific for dominant epitopes are characterized by a diverse Vbeta repertoire, whereas those specific for subdominant epitopes employ a dramatically more focused Vbeta repertoire. We also demonstrate that dominant epitope-specific CD8(+) T lymphocytes employ TCRs with multiple CDR3 lengths, whereas subdominant epitope-specific cells employ TCRs with a more restricted CDR3 length. Thus, the relative dominance of an epitope-specific CD8(+) T-lymphocyte response reflects the clonal diversity of that response. These findings suggest that the limited clonal repertoire of subdominant epitope-specific CD8(+) T-lymphocyte populations may limit the ability of these epitope-specific T-lymphocyte populations to expand and therefore limit the ability of these cell populations to contribute to the control of viral replication.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17035327      PMCID: PMC1676269          DOI: 10.1128/JVI.01479-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  Immunodomination in the evolution of dominant epitope-specific CD8+ T lymphocyte responses in simian immunodeficiency virus-infected rhesus monkeys.

Authors:  Michael H Newberg; Kimberly J McEvers; Darci A Gorgone; Michelle A Lifton; Susanne H C Baumeister; Ronald S Veazey; Jörn E Schmitz; Norman L Letvin
Journal:  J Immunol       Date:  2006-01-01       Impact factor: 5.422

Review 2.  Dominance and crypticity of T cell antigenic determinants.

Authors:  E E Sercarz; P V Lehmann; A Ametani; G Benichou; A Miller; K Moudgil
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

3.  Expression of two T cell receptor alpha chains: dual receptor T cells.

Authors:  E Padovan; G Casorati; P Dellabona; S Meyer; M Brockhaus; A Lanzavecchia
Journal:  Science       Date:  1993-10-15       Impact factor: 47.728

4.  Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.

Authors:  R A Koup; J T Safrit; Y Cao; C A Andrews; G McLeod; W Borkowsky; C Farthing; D D Ho
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

5.  Conserved T-cell receptor repertoire in simian immunodeficiency virus-infected rhesus monkeys.

Authors:  Z W Chen; Z C Kou; L Shen; K A Reimann; N L Letvin
Journal:  J Immunol       Date:  1993-08-15       Impact factor: 5.422

6.  Sequence and diversity of rhesus monkey T-cell receptor beta chain genes.

Authors:  G Levinson; A L Hughes; N L Letvin
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

7.  Characterization of the human T cell receptor alpha-chain repertoire and demonstration of a genetic influence on V alpha usage.

Authors:  P A Moss; W M Rosenberg; E Zintzaras; J I Bell
Journal:  Eur J Immunol       Date:  1993-05       Impact factor: 5.532

8.  Cytotoxic T lymphocytes do not appear to select for mutations in an immunodominant epitope of simian immunodeficiency virus gag.

Authors:  Z W Chen; L Shen; M D Miller; S H Ghim; A L Hughes; N L Letvin
Journal:  J Immunol       Date:  1992-12-15       Impact factor: 5.422

9.  The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.

Authors:  A Sette; A Vitiello; B Reherman; P Fowler; R Nayersina; W M Kast; C J Melief; C Oseroff; L Yuan; J Ruppert; J Sidney; M F del Guercio; S Southwood; R T Kubo; R W Chesnut; H M Grey; F V Chisari
Journal:  J Immunol       Date:  1994-12-15       Impact factor: 5.422

10.  The life span of naive alpha/beta T cells in secondary lymphoid organs.

Authors:  H von Boehmer; K Hafen
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307

View more
  16 in total

1.  DNA/Ad5 vaccination with SIV epitopes induced epitope-specific CD4⁺ T cells, but few subdominant epitope-specific CD8⁺ T cells.

Authors:  Lara Vojnov; Alexander T Bean; Eric J Peterson; Maria J Chiuchiolo; Jonah B Sacha; Ferencz S Denes; Matyas Sandor; Deborah H Fuller; James T Fuller; Christopher L Parks; Adrian B McDermott; Nancy A Wilson; David I Watkins
Journal:  Vaccine       Date:  2011-08-10       Impact factor: 3.641

2.  Complementarity-determining region 3 size spectratypes of T cell receptor beta chains in CD8+ T cells following antiviral treatment of chronic hepatitis B.

Authors:  Shi-Wu Ma; Yong-Yin Li; Guang-Wen Zhang; Xuan Huang; Jian Sun; Chris Li; William G H Abbott; Jin-Lin Hou
Journal:  Antimicrob Agents Chemother       Date:  2010-11-22       Impact factor: 5.191

3.  A non-human primate model for analysis of safety, persistence, and function of adoptively transferred T cells.

Authors:  C Berger; M Berger; D Anderson; S R Riddell
Journal:  J Med Primatol       Date:  2010-11-02       Impact factor: 0.667

4.  Diverse peptide presentation of rhesus macaque major histocompatibility complex class I Mamu-A 02 revealed by two peptide complex structures and insights into immune escape of simian immunodeficiency virus.

Authors:  Jun Liu; Lianpan Dai; Jianxun Qi; Feng Gao; Youjun Feng; Wenjun Liu; Jinghua Yan; George F Gao
Journal:  J Virol       Date:  2011-05-11       Impact factor: 5.103

5.  Vaccine injection site matters: qualitative and quantitative defects in CD8 T cells primed as a function of proximity to the tumor in a murine glioma model.

Authors:  John R Ohlfest; Brian M Andersen; Adam J Litterman; Junzhe Xia; Christopher A Pennell; Lauryn E Swier; Andres M Salazar; Michael R Olin
Journal:  J Immunol       Date:  2012-12-17       Impact factor: 5.422

6.  Clonal focusing of epitope-specific CD8+ T lymphocytes in rhesus monkeys following vaccination and simian-human immunodeficiency virus challenge.

Authors:  Pritha Sen; William A Charini; Ramu A Subbramanian; Edwin R Manuel; Marcelo J Kuroda; Patrick A Autissier; Norman L Letvin
Journal:  J Virol       Date:  2007-10-31       Impact factor: 5.103

7.  Dominant CD8+ T-lymphocyte responses suppress expansion of vaccine-elicited subdominant T lymphocytes in rhesus monkeys challenged with pathogenic simian-human immunodeficiency virus.

Authors:  Edwin R Manuel; Wendy W Yeh; Michael S Seaman; Kathryn Furr; Michelle A Lifton; Sandrine L Hulot; Patrick Autissier; Norman L Letvin
Journal:  J Virol       Date:  2009-07-29       Impact factor: 5.103

8.  Diverse cross-reactive potential and Vbeta gene usage of an epitope-specific cytotoxic T-lymphocyte population in monkeys immunized with diverse human immunodeficiency virus type 1 Env immunogens.

Authors:  Sandrine L Hulot; Michael S Seaman; Pritha Sen; Patrick A Autissier; Edwin R Manuel; Norman L Letvin
Journal:  J Virol       Date:  2009-07-29       Impact factor: 5.103

9.  Limited maintenance of vaccine-induced simian immunodeficiency virus-specific CD8 T-cell receptor clonotypes after virus challenge.

Authors:  Miranda Z Smith; Tedi E Asher; Vanessa Venturi; Miles P Davenport; Daniel C Douek; David A Price; Stephen J Kent
Journal:  J Virol       Date:  2008-05-28       Impact factor: 5.103

10.  Extraction and characterization of the rhesus macaque T-cell receptor beta-chain genes.

Authors:  Hui Yee Greenaway; Monica Kurniawan; David A Price; Daniel C Douek; Miles P Davenport; Vanessa Venturi
Journal:  Immunol Cell Biol       Date:  2009-06-09       Impact factor: 5.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.